Ran Nussbaum Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ran Nussbaum.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ran Nussbaum. Ran Nussbaum is a Director in ARQULE INC ($ARQL) and a in Eloxx Pharmaceuticals, Inc. ($ELOX) and a Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and a Director in Kite Pharma, Inc. ($KITE) and a Director in Keros Therapeutics, Inc. ($KROS) and a Director in UroGen Pharma Ltd. ($URGN) and a Director in Prevail Therapeutics Inc. ($PRVL).
Address: C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA 90404 CA
Companies in which Ran Nussbaum is an Insider
ARQULE INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 16 2020
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eloxx Pharmaceuticals, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Ran Nussbaum: Director
Holdings: 1,791,470 shares
Current Value: $412,038
Latest Transaction: May 17 2021
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Keros Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ran Nussbaum: Director
Holdings: 2,288,151 shares
Latest Transaction: Nov 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kite Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prevail Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ran Nussbaum: Director
Holdings: 0 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
UroGen Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ran Nussbaum: Director
Holdings: 1,465,199 shares
Latest Transaction: Apr 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ran Nussbaum
Sentiment: All, ARQL, ELOX, KROS, KITE, PRVL, URGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
| May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
| May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
| May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Option Exercise | M | 5.00 | 1,030 | 5,150 | 0 | |
| Apr 22 2021 | URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Buy | M | 5.00 | 1,030 | 5,150 | 1,465,199 | 1.5 M to 1.5 M (+0.07 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 |